MRNA uses the cell’s machinery to synthesize proteins that are supposed to resemble the spike protein of the coronavirus, which is what the virus uses to enter cells via the ACE2 receptor. These proteins are then identified by the immune system, which builds antibodies against them. The concern many experts had is that these proteins could accumulate in the body – especially in regions of high concentration of ACE2 receptors – like the testicles and ovaries.
According to newly obtained research, these concerns appear to be a reality. If the immune system attacks the location where these proteins accumulate, then an auto-immune condition, among other serious conditions are highly likely. Many doctors are already recommending forgoing the vaccine for patients who have a pre-existing autoimmune disorder.
Dr. Bridle and a group of international scientists filed a request for information on the accumulation concern from the Japanese regulatory agency, and received access to what’s called the “biodistribution study.”
“Until now we were assuming that these were acting like traditional vaccines, where they go in the shoulder muscle and they don’t go anywhere else. However what this data shows us… is that more than three quarters of the dose is no longer present at the injection site in the shoulder… It turns out these are traveling all throughout the body,” Bridle said on a conference call showing accumulation in many organs including the ovaries.
This new research shows that the coronavirus spike protein from COVID-19 vaccination unexpectedly enters the bloodstream, which is a plausible explanation for the tens of thousands of reported blood clots, as well brain and reproductive damage, the Canadian cancer vaccine researcher said last week.
“We thought the spike protein was a great target antigen, we never knew the spike protein itself was a toxin and was a pathogenic protein. So by vaccinating people we are inadvertently inoculating them with a toxin,” Bridle said.
Bridle is a renowned vaccine researcher who was awarded a $230,000 government grant last year for research on COVID vaccine development.
“It’s the first time ever scientists have been privy to seeing where these messenger RNA [mRNA] vaccines go after vaccination,” said Bridle. “Is it a safe assumption that it stays in the shoulder muscle? The short answer is: absolutely not. It’s very disconcerting.”
Dr. David Martin, founder and chairman of M-CAM Inc, challenges our presuppositions about the new mRNA Covid-19 vaccines. Quoting the pharmaceutical companies themselves, David suggests that these are not vaccines, but, in actuality, gene therapy. He explains what the vaccines may do to us, what they are promising they can do for us, and how to distinguish the difference.
“It’s not somewhat different. It’s not the same at all. This is a public manipulation of misrepresentation of clinical treatment. It’s not a vaccination,” said Doctor Martin.
Latest VAERS Data Show 5,165 Deaths Reported Following COVID Vaccines
VAERS, the CDC’s primary mechanism in the U.S. for reporting adverse vaccine reactions, historically only reports 1% of actual adverse events according to a Harvard study.
This week’s number of reported deaths among all age groups following COVID vaccines passed the 5,000 mark, up 759 from last week, according to data released this week.
If VAERS only reports approximately 1% of adverse events from vaccines, the hundreds of thousands already reported to VAERS by healthcare professionals could possibly be in the millions.
The newest data show that between Dec. 14, 2020 and May 28, a total of 294,801 total adverse events were reported to VAERS, including 5,165 deaths — an increase of 759 over the previous week. There were 25,359 serious injuries reported, up 3,822 compared with last week.
An article on seven U.S. teen boys in several states, published online Friday in Pediatrics, is among the latest reports of heart inflammation discovered after COVID-19 vaccination.
According to a report from June 2, Israeli health officials found a probable link between Pfizer’s COVID vaccine, and dozens of cases of heart inflammation in young men following the second dose.
A study by Israeli health officials identified 275 cases of myocarditis in Israel between December 2020 and May 2021, including 148 cases that occurred within a month after vaccination. Of those 148 cases, 27 occurred after the first dose and 121 after the second dose. About half of the cases involved people with previous medical conditions.
Many of the cases were reported among men 16 to 30 years old, and most often in 16- to 19-year-olds.
Natural Immunity Over Immunity from Vaccines
During another Zoom meeting with Viral immunologist, Dr. Byram Bridle, another expert went on to talk about why the quality of natural immunity is likely better than the immunity received from the MRNA vaccines.
A recent report by the New York Times, showed that people who have been naturally infected with coronavirus have natural immunity that will likely last for years, and maybe forever.
“After infection, most people who have recovered still have enough immune cells to fend off the virus and prevent illness, the new data show. A slow rate of decline in the short term suggests, happily, that these cells may persist in the body for a very, very long time to come,” the New York Times reports.
For most viruses it is generally the scientific consensus that natural infection provides a better and more robust immunity than vaccines are able to. One of the only viruses where we know definitively this is not the case, is the Human papillomavirus infection or HPV.
For example, a recent SIREN study conducted in the UK at the Public Health England (PHE) involving over 20,000 healthcare professionals has discovered that immunity derived by natural COVID-19 infection is stronger and more effective at warding off the novel coronavirus than the vaccine developed by Oxford-AstraZeneca.
A U.S.-based vaccine company, MERK, also announced on Jan. 25th that they will stop developing vaccines for the coronavirus since natural infections are better than vaccines in producing results leading to herd immunity.